Mithramycin A and Mithralog EC-8042 inhibit SETDB1 expression and its oncogenic activity in malignant melanoma - Federico, Aniello; Steinfass, Tamara; Larribere, Lionel; Novak, Daniel; Morís, Francisco; Núñez, Luz-Elena; Umansky, Viktor; Utikal, Jochen (Molecular therapy. Oncolytics, 2020)
Gesehen am 26.08.2025